go to contents

RIANA Therapeutics GmbH
Developing novel anti-cancer therapies

Back to list

Facts

Founded
08.02.2023
Staff
3
Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health

Profile

RIANA Therapeutics' approach to drug discovery is based on its proprietary platform technology for discovering compounds that target cancer-promoting protein-protein interactions (PPIs). Using this novel approach, RIANA is searching for inhibitors that block the formation of specific oncogenic PPIs. RIANA is currently working to develop new compounds that specifically target acute myeloid leukemia (AML) as well as other blood cancers and certain types of solid tumors.

Similar companies in RDM biotech/pharma

Bionorica Research GmbH

Organization type
RDM biotech/pharma
Region
Tyrol
Cluster
Life Sciences Tyrol
Focus
human health
Details

ViruSure GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Fresenius Kabi Austria GmbH

Organization type
RDM biotech/pharma
Region
Styria
Focus
animal health
Details

Richard Bittner AG

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
human health
Details

Contact

Veterinaerplatz 1
Vienna
Vienna

Contact: Anna Orlova, PhD
Email: anna.orlova@rianatx.com
Website